- Home
- Publications
- Publication Search
- Publication Details
Title
Proteolysis targeting chimeras in antiviral research
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume -, Issue -, Pages -
Publisher
Future Science Ltd
Online
2022-02-09
DOI
10.4155/fmc-2022-0005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted protein degraders crowd into the clinic
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Protein degradation: a novel computational approach to design protein degrader probes for main protease of SARS-CoV-2
- (2021) Muhammed Shaheer et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Indomethacin-based PROTACs as pan-coronavirus antiviral agents
- (2021) Jenny Desantis et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus Activity
- (2021) Friedrich Hahn et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted protein degradation at the host–pathogen interface
- (2021) Christoph Grohmann et al. MOLECULAR MICROBIOLOGY
- The PROTAC gold rush
- (2021) Ken Garber NATURE BIOTECHNOLOGY
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- The Development of Coronavirus 3C-Like Protease (3CLpro) Inhibitors from 2010 to 2020
- (2020) Yuzhi Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Could PROTACs Protect Us From COVID-19?
- (2020) Wilnelly Martinez-Ortiz et al. DRUG DISCOVERY TODAY
- Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
- (2020) David E. Gordon et al. SCIENCE
- Targeting the SARS-CoV-2 RNA Genome with Small Molecule Binders and Ribonuclease Targeting Chimera (RIBOTAC) Degraders
- (2020) Hafeez S. Haniff et al. ACS Central Science
- Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses
- (2020) Marianna Tampere et al. Viruses-Basel
- Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions
- (2020) Pranam Chatterjee et al. Communications Biology
- Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations
- (2019) Mélissanne de Wispelaere et al. Nature Communications
- Design of a PROTAC that antagonizes and destroys the cancer-forming X-protein of the hepatitis B virus
- (2014) Kristopher Montrose et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
- (2013) Kai Lin et al. ANTIVIRAL RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started